Product Development Pipeline

Our innovative approach to drug development has resulted in multiple product candidates progressing in development that we believe offer significant new promise to patient populations that currently have no or limited treatment options. Each novel, differentiated drug candidate is the result of application of our proprietary RAMP drug innovation and/or prodrug technology engines to the same clinically validated kinase target.

Inhibikase Pipeline

Back to Top